Navigation Links
Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
Date:5/11/2010

PORTOLA VALLEY, Calif., May 11 /PRNewswire/ -- Spectros, developer and manufacturer of advanced molecular sensing and imaging devices which shed light on life-threatening diseases, presented 4 papers at the annual PAS conference held in Vancouver, B.C. May 1-4, 2010. The presented papers confirm the value added when using the T-Stat VLS tissue oximeter in neonates and infants for the detection of ischemia. The noninvasive white LED sensors provide a gentle way of monitoring, which is sensitive to this very delicate patient population.

"The abstracts and posters presented at PAS show a level of commitment from leading institutions and their support of the T-Stat in the critical care setting," comments Robert Kum, Director of Commercial Development. "Medical professionals depend on the T-Stat VLS Tissue Oximeter to get a clear view of tissue saturation, which enables them to make timely, more informed patient care decisions."

Duke University in Durham, NC put together a study on red blood cell transfusions and mesenteric perfusion in preterm infants.  The Pediatrics and Neonatology department at Georgetown University Hospital in Washington, DC presented the validation of visible light tissue oximetry in newborn infants. Noninvasive measurement of local tissue perfusion and its correlation with hemodynamic indices during transition in term infants was completed by The Children's Hospital at OU Medical Center in Oklahoma City, OK and postoperative differences in regional tissue oxygenation and fractional oxygen extraction (FTOE) in newborn infants with hypoplastic left heart syndrome (HLHS) and transposition of great arteries (TGA) was conducted at Columbia University in New York, NY.

"These studies have helped to define normal tissue oxygen extraction in newborn infants, for term, pre-term and congenital heart defect patients (hypoplastic left heart syndrome and transposition of the great arteries)," said Michael Fierro, Director of Research and Development. "These studies form the foundation for the work that Spectros and clinicians are currently exploring to define the clinical benefit of having an absolute, accurate, and reliable measure of tissue oxygen saturation in the newborn patient population."

About Spectros

Spectros markets and licenses advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's champion product, the T-Stat VLS Tissue Oximeter, is the first medical device FDA-approved as sensitive to ischemia, an insufficient supply of oxygen to tissue. T-Stat is the only commercially-available tissue oximeter that utilizes state-of-the-art multispectral visible light spectroscopy (VLS) technology. The noninvasive T-Stat VLS system is used clinically to provide a continuous and real-time absolute value, allowing for earlier diagnosis and lower costs. Spectros also develops molecular diagnostic tools for breast and prostate cancer, currently in phase I/II clinical trials supported by the National Cancer Institute. Spectros is a venture-supported private concern and markets its products in the U.S. and internationally.

(Note:  Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor a guarantee of future events or returns.  Certain Spectros applications described above have not been reviewed and approved by the FDA, and are therefore labeled for investigational use only.  T-Stat and Continuum are trademarks of the Spectros Corporation.)

For further information, visit www.spectros.com


'/>"/>
SOURCE Spectros
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spectros Corp. Enters Into Optical Biotechnology Patent Sale Agreement With Philips Electronics N.V.
2. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
3. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
4. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
5. County of Los Angeles Fire Museum Presents Pioneers of Paramedicine(TM) Lifetime Achievement Award
6. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
7. Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Association for Cancer Research
8. PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention
9. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
10. Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease
11. Limbs for Life Foundation Presents the Roaring 20s at 9th Annual Benefit Gala and Auction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... , June 24, 2016 ... the "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural ... Structural electronics involves electronic and/or ... protective structures, replacing dumb structures such as vehicle ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):